Elafibranor Completed Phase 2 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01261494Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus